您的位置: 首页 > 2017年7月 第48卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

PBK在前列腺癌组织中的表达及临床意义

Expression and clinical significance of PBK in prostate cancer tissues

来源期刊: 广州医药 | 1-6 发布时间:2021-12-01 收稿时间:2025/11/13 17:10:19 阅读量:26
作者:
关键词:
前列腺癌PBK生化复发
Prostate cancerPBKBiochemical recurrence
DOI:
10.3969/j.issn.1000-8535.2017.04.001
收稿时间:
2017-03-20 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 分析PBK在前列腺癌中的表达及临床意义。方法 利用前列腺癌的组织芯片,包含98例前列腺癌及81例对照癌旁组织作为研究对象,免疫组化方法检测PBK的表达情况,并运用统计学方法分析免疫组化芯片及Taylor数据库中PBK表达与前列腺癌临床病理特征之间的关系。结果 PBK在前列腺癌中表达明显升高(P=0.001);且在Gleason高评分组的表达比低评分组表达升高(P=0.001)。Taylor数据库得到相似结果,且运用Kaplan-Meier分析发现PBK与无生化复发生存率显著相关(P=0.007),最后采用Cox回归模型进行多因素综合分析发现在影响前列腺癌预后的队列中,PBK高表达(P=0.041)与Gleason评分、病理分期都是前列腺癌生化复发的独立预测指标。结论 PBK的表达与前列腺癌密切相关,可作为临床诊断及治疗的分子标志物。
Objective To investigate the expression and clinical significance of PBK in prostate cancer. Methods Using tissue microarrays of prostate cancer, which including 98 cases of prostate cancer and 81 cases of normal tissue adjacent to cancer as the research object, the expression of PBK was detected by immunohistochemistry, and statistical analysis was used to analyze the relationship between the expression of PBK and the clinicopathological features of prostate cancer in the microarray and Taylor database. Results The expression of PBK in prostate cancer was significantly higher (P=0.001), and the expression increased in the group of high Gleason score (P=0.001). The Taylor database obtained similar results, and Kaplan-Meier analysis showed that PBK was significantly correlated with the biochemical recurrence free survival (P=0.007). Finally, Cox regression model was used to analyze the prognostic factors of prostate cancer. Result shows that, the high expression of PBK (P=0.041), Gleason score and pathological stage were independent predictors of biochemical recurrence of prostate cancer. Conclusion The expression of PBK is closely related to prostate cancer, and can be used as a molecular marker for clinical diagnosis and treatment.
1、 FUJIBUCHI T, ABE Y, TAKEUCHI T, et al. Expression and phosphorylation of TOPK during spermatogenesis[J]. Dev Growth Differ,2006, 47(9):637-644. FUJIBUCHI T, ABE Y, TAKEUCHI T, et al. Expression and phosphorylation of TOPK during spermatogenesis[J]. Dev Growth Differ,2006, 47(9):637-644.
2、 LENGAUER C, KINZLER K W, VOGELSTEIN B. Genetic instability in colorectal cancers[J]. Nature,1997,386(6625):623-627. LENGAUER C, KINZLER K W, VOGELSTEIN B. Genetic instability in colorectal cancers[J]. Nature,1997,386(6625):623-627.
3、 ISHIDA S, HUANG E, ZU Z H, et al. Role for E2F in control ofboth DNA replication and mitotic functions as revealed from DNA microarray analysis[J]. Mol Cell Biol,2001,21(14):4684-4699. ISHIDA S, HUANG E, ZU Z H, et al. Role for E2F in control ofboth DNA replication and mitotic functions as revealed from DNA microarray analysis[J]. Mol Cell Biol,2001,21(14):4684-4699.
4、 MATSUMOTO S, ABE Y, FUJIBUCHI T, et al. Characterization of a MAPKK-like protein kinase TOPK[J]. Biophys Res Commun,2004,325(3):997-1004. MATSUMOTO S, ABE Y, FUJIBUCHI T, et al. Characterization of a MAPKK-like protein kinase TOPK[J]. Biophys Res Commun,2004,325(3):997-1004.
5、 PSTEIN J I, ALLSBROOK W C, JR.AMIN M B, et al. The 2005 International society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma[J]. Am J Surg Pathol,2005,40(2):1228-1242. PSTEIN J I, ALLSBROOK W C, JR.AMIN M B, et al. The 2005 International society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma[J]. Am J Surg Pathol,2005,40(2):1228-1242.
6、 NANDI A K, RAPOPORT A P. Expression of PDZ-binding kinase (PBK) is regulated by cell cycles pecific transcription factors E2F and CREB/ATF[J]. Leuk Res,2006,30(4): 437-447. NANDI A K, RAPOPORT A P. Expression of PDZ-binding kinase (PBK) is regulated by cell cycles pecific transcription factors E2F and CREB/ATF[J]. Leuk Res,2006,30(4): 437-447.
7、 ZYKOVA T A, ZHU F, LU C, et al. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells[J]. Clin Cancer Res,2007,12(23): 6884-6893. ZYKOVA T A, ZHU F, LU C, et al. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells[J]. Clin Cancer Res,2007,12(23): 6884-6893.
8、 PARK J H, LIN M L, NISHIDATE T, et al. PDZ-binding kinase/T-LAK cell originated protein kinase, a putative cancer/testisantigen with an oncogenic activity in breast cancer[J]. Cancer Res, 2006,66(18): 9186-9195. PARK J H, LIN M L, NISHIDATE T, et al. PDZ-binding kinase/T-LAK cell originated protein kinase, a putative cancer/testisantigen with an oncogenic activity in breast cancer[J]. Cancer Res, 2006,66(18): 9186-9195.
9、 NANDI A, TIDWELL M, J KARP, et al. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells[J]. Blood Cells Mol Dis,2004,32(1): 240-245. NANDI A, TIDWELL M, J KARP, et al. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells[J]. Blood Cells Mol Dis,2004,32(1): 240-245.
10、 SIMONS-EVELYN M,BAILEY-DELL K,TORETSKY J A, et al. PBK/TOPK Is a novel mitotic kinase which is upregulated in burkitt's lymphoma and other highly proliferative malignant cells[J]. Blood Cells Mol Dis,2001,27(5): 825-829. SIMONS-EVELYN M,BAILEY-DELL K,TORETSKY J A, et al. PBK/TOPK Is a novel mitotic kinase which is upregulated in burkitt's lymphoma and other highly proliferative malignant cells[J]. Blood Cells Mol Dis,2001,27(5): 825-829.
11、 ZHU F, ZYKOVA T A, KANG B S, et al. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells[J]. Gastroenterology,2007,133 (1) 219-231. ZHU F, ZYKOVA T A, KANG B S, et al. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells[J]. Gastroenterology,2007,133 (1) 219-231.
12、 GAUDET S, BRANTON D, LUE R A. Characterization of PDZ-binding kinase, a mitotic kinase[J]. Proc Natl Acad Sci,2000,97 (10) :5167-5172. GAUDET S, BRANTON D, LUE R A. Characterization of PDZ-binding kinase, a mitotic kinase[J]. Proc Natl Acad Sci,2000,97 (10) :5167-5172.
13、 ABE Y, MATSUMOTO S, KITO K, et al. Cloning and expression of a novel MAPKK-like protein kinase, lymphokineactivated killer t-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells[J]. J Biol Chem,2000,275 (28):21525-21531. ABE Y, MATSUMOTO S, KITO K, et al. Cloning and expression of a novel MAPKK-like protein kinase, lymphokineactivated killer t-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells[J]. J Biol Chem,2000,275 (28):21525-21531.
14、 SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics,2013[J]. Ca Cancer J Clin,2013,63 (1):11-30. SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics,2013[J]. Ca Cancer J Clin,2013,63 (1):11-30.
下一篇
出版者信息








《广州医药》公众号
目录